France / CIS 67877234

OCTAPLEX 1000 UI, poudre et solvant pour solution pour perfusion

poudre et solvant pour solution pour perfusion · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formpoudre et solvant pour solution pour perfusion
Routeintraveineuse
Ingredient entries6
CountryFrance

Product identity

At a glance

Authorisation holder
OCTAPHARMA FRANCE
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 67877234

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for OCTAPLEX 1000 UI, poudre et solvant pour solution pour perfusion
IngredientStrength / referenceSource role
FACTEUR II DE COAGULATION HUMAIN poudre560 - 1520 UIun flaconSAGroup 1
FACTEUR X DE COAGULATION HUMAIN poudre720 - 1200 UIun flaconSAGroup 4
FACTEUR IX DE COAGULATION HUMAIN poudre1000 UIun flaconSAGroup 3
PROTÉINE S poudre480 - 1280 UIun flaconSAGroup 6
FACTEUR VII DE COAGULATION HUMAIN poudre360 - 960 UIun flaconSAGroup 2
PROTÉINE C HUMAINE poudre520 - 1240 UIun flaconSAGroup 5

Pack references

Presentations (1)

1 flacon(s) poudre en verre - 1 flacon(s) solvant en verre de 40 mL avec dispositif(s) de transfert Nextaro®

CIP13 3400955015109

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 67877234 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →